Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement - PubMed (original) (raw)
. 2018 Jan 23;319(4):388-396.
doi: 10.1001/jama.2017.19163.
David Moher 2, Brett D Thombs 3 4, Trevor A McGrath 5, Patrick M Bossuyt 6; and the PRISMA-DTA Group; Tammy Clifford 7, Jérémie F Cohen 8 9, Jonathan J Deeks 10, Constantine Gatsonis 11, Lotty Hooft 12, Harriet A Hunt 13, Christopher J Hyde 13, Daniël A Korevaar 6, Mariska M G Leeflang 6, Petra Macaskill 14, Johannes B Reitsma 12, Rachel Rodin 15, Anne W S Rutjes 16, Jean-Paul Salameh 2 17, Adrienne Stevens 18 19, Yemisi Takwoingi 10, Marcello Tonelli 20, Laura Weeks 7, Penny Whiting 21, Brian H Willis 10
Affiliations
- PMID: 29362800
- DOI: 10.1001/jama.2017.19163
Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement
Matthew D F McInnes et al. JAMA. 2018.
Erratum in
- Incorrect Terminology in Table 2.
[No authors listed] [No authors listed] JAMA. 2019 Nov 26;322(20):2026. doi: 10.1001/jama.2019.18307. JAMA. 2019. PMID: 31769809 Free PMC article. No abstract available.
Abstract
Importance: Systematic reviews of diagnostic test accuracy synthesize data from primary diagnostic studies that have evaluated the accuracy of 1 or more index tests against a reference standard, provide estimates of test performance, allow comparisons of the accuracy of different tests, and facilitate the identification of sources of variability in test accuracy.
Objective: To develop the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagnostic test accuracy guideline as a stand-alone extension of the PRISMA statement. Modifications to the PRISMA statement reflect the specific requirements for reporting of systematic reviews and meta-analyses of diagnostic test accuracy studies and the abstracts for these reviews.
Design: Established standards from the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network were followed for the development of the guideline. The original PRISMA statement was used as a framework on which to modify and add items. A group of 24 multidisciplinary experts used a systematic review of articles on existing reporting guidelines and methods, a 3-round Delphi process, a consensus meeting, pilot testing, and iterative refinement to develop the PRISMA diagnostic test accuracy guideline. The final version of the PRISMA diagnostic test accuracy guideline checklist was approved by the group.
Findings: The systematic review (produced 64 items) and the Delphi process (provided feedback on 7 proposed items; 1 item was later split into 2 items) identified 71 potentially relevant items for consideration. The Delphi process reduced these to 60 items that were discussed at the consensus meeting. Following the meeting, pilot testing and iterative feedback were used to generate the 27-item PRISMA diagnostic test accuracy checklist. To reflect specific or optimal contemporary systematic review methods for diagnostic test accuracy, 8 of the 27 original PRISMA items were left unchanged, 17 were modified, 2 were added, and 2 were omitted.
Conclusions and relevance: The 27-item PRISMA diagnostic test accuracy checklist provides specific guidance for reporting of systematic reviews. The PRISMA diagnostic test accuracy guideline can facilitate the transparent reporting of reviews, and may assist in the evaluation of validity and applicability, enhance replicability of reviews, and make the results from systematic reviews of diagnostic test accuracy studies more useful.
Similar articles
- Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
Elsman EBM, Mokkink LB, Terwee CB, Beaton D, Gagnier JJ, Tricco AC, Baba A, Butcher NJ, Smith M, Hofstetter C, Aiyegbusi OL, Berardi A, Farmer J, Haywood KL, Krause KR, Markham S, Mayo-Wilson E, Mehdipour A, Ricketts J, Szatmari P, Touma Z, Moher D, Offringa M. Elsman EBM, et al. Health Qual Life Outcomes. 2024 Jul 9;22(1):48. doi: 10.1186/s12955-024-02256-9. Health Qual Life Outcomes. 2024. PMID: 38978063 Free PMC article. - Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
Elsman EBM, Mokkink LB, Terwee CB, Beaton D, Gagnier JJ, Tricco AC, Baba A, Butcher NJ, Smith M, Hofstetter C, Aiyegbusi OL, Berardi A, Farmer J, Haywood KL, Krause KR, Markham S, Mayo-Wilson E, Mehdipour A, Ricketts J, Szatmari P, Touma Z, Moher D, Offringa M. Elsman EBM, et al. J Patient Rep Outcomes. 2024 Jul 9;8(1):64. doi: 10.1186/s41687-024-00727-7. J Patient Rep Outcomes. 2024. PMID: 38977535 Free PMC article. - Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
Elsman EBM, Mokkink LB, Terwee CB, Beaton D, Gagnier JJ, Tricco AC, Baba A, Butcher NJ, Smith M, Hofstetter C, Aiyegbusi OL, Berardi A, Farmer J, Haywood KL, Krause KR, Markham S, Mayo-Wilson E, Mehdipour A, Ricketts J, Szatmari P, Touma Z, Moher D, Offringa M. Elsman EBM, et al. Qual Life Res. 2024 Aug;33(8):2029-2046. doi: 10.1007/s11136-024-03634-y. Epub 2024 Jul 9. Qual Life Res. 2024. PMID: 38980635 Free PMC article. - Recommendations for reporting of systematic reviews and meta-analyses of diagnostic test accuracy: a systematic review.
McGrath TA, Alabousi M, Skidmore B, Korevaar DA, Bossuyt PMM, Moher D, Thombs B, McInnes MDF. McGrath TA, et al. Syst Rev. 2017 Oct 10;6(1):194. doi: 10.1186/s13643-017-0590-8. Syst Rev. 2017. PMID: 29017574 Free PMC article. Review. - A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement.
Lee H, Cashin AG, Lamb SE, Hopewell S, Vansteelandt S, VanderWeele TJ, MacKinnon DP, Mansell G, Collins GS, Golub RM, McAuley JH; AGReMA group; Localio AR, van Amelsvoort L, Guallar E, Rijnhart J, Goldsmith K, Fairchild AJ, Lewis CC, Kamper SJ, Williams CM, Henschke N. Lee H, et al. JAMA. 2021 Sep 21;326(11):1045-1056. doi: 10.1001/jama.2021.14075. JAMA. 2021. PMID: 34546296 Free PMC article.
Cited by
- Helicobacter pylori eradication following endoscopic resection might prevent metachronous gastric cancer: a systematic review and meta-analysis of studies from Japan and Korea.
Yu TH, Bai D, Liu K, Zhang WH, Chen XZ, Hu JK. Yu TH, et al. Front Med (Lausanne). 2024 Sep 2;11:1393498. doi: 10.3389/fmed.2024.1393498. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39286646 Free PMC article. - Impact of Indocyanine Green Dose on Sentinel Lymph Node Mapping in Cervical Cancer: A Systematic Review.
Laufer J, Scasso S, Papadia A. Laufer J, et al. Cancers (Basel). 2024 Sep 8;16(17):3107. doi: 10.3390/cancers16173107. Cancers (Basel). 2024. PMID: 39272965 Free PMC article. Review. - Diagnostic accuracy of microvascular flow imaging ultrasound for endoleak detection after endovascular aortic aneurysm repair: a systematic review and meta-analysis.
Czeczelewski M, Kopyto E, Kuczyńska M, Drelich-Zbroja A, Jargiełło T. Czeczelewski M, et al. Pol J Radiol. 2024 Aug 22;89:e414-e419. doi: 10.5114/pjr/190502. eCollection 2024. Pol J Radiol. 2024. PMID: 39257925 Free PMC article. Review. - Accuracy of controlled attenuation parameter for liver steatosis in patients at risk for metabolic dysfunction-associated steatotic liver disease using magnetic resonance imaging: a systematic review and meta-analysis.
Malandris K, Katsoula A, Liakos A, Bekiari E, Karagiannis T, Theocharidou E, Giouleme O, Sinakos E, Tsapas A. Malandris K, et al. Ann Gastroenterol. 2024 Sep-Oct;37(5):579-587. doi: 10.20524/aog.2024.0910. Epub 2024 Aug 19. Ann Gastroenterol. 2024. PMID: 39238800 Free PMC article.
Publication types
MeSH terms
Grants and funding
- G0701649/MRC_/Medical Research Council/United Kingdom
- MR/N007999/1/MRC_/Medical Research Council/United Kingdom
- PDF-2017-10-059/DH_/Department of Health/United Kingdom
- CIHR/Canada
LinkOut - more resources
Full Text Sources
Other Literature Sources